Loading company…
Yanyang develops live bacterial therapies and other microecological health products.
Yanyang researches bacterial products for conditions including tumors, metabolic diseases and chemotherapy-related diarrhea. Its work includes anaerobic microorganism screening and live bacteria storage. Founded in 2019 and based in Chengdu, China, it raised Series A+ funding from Tao Capital in January 2026.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in